Product Listing: Alectinib Impurities

Alectinib is a targeted therapy used for the treatment of non-small cell lung cancer. However, during the manufacturing process, impurities may be present in the final product. The presence of impurities can affect the safety and efficacy of the drug. Therefore, it is important to control and monitor the levels of impurities in Alectinib to ensure its quality and safety for human consumption.

Alectinib is a medication used to treat certain types of lung cancer. However, it is important to ensure that the medication is of high quality and purity. Alectinib impurities are substances that may be present in the medication that can affect its quality and effectiveness. It is important to monitor and control these impurities to ensure the safety and efficacy of the medication.

PRODUCT	CAT NO.	CATEGORY
Alectinib De-carboxylate impurity	CS-O-46849	Impurities
Alectinib Morpholine N-oxide	CS-O-35981	Impurities
N-Nitroso Alectinib	CS-O-38948	Impurities

Other Reference Standards of Alectinib

PRODUCT	CAT NO.	CATEGORY
Alectinib D5	CS-P-08187	Stable Isotopes
Alectinib D6	CS-P-08188	Stable Isotopes
Alectinib D8	CS-CX-00065	Stable Isotopes
Alectinib M4 metabolite D4	CS-O-32642	Stable Isotopes
Alectinib	CS-T-50375	API Standards
Alectinib Hydrochloride	CS-T-69135	API Standards
Alectinib Metabolite M4	CS-O-16973	Metabolites
Alectinib M1a	CS-O-32475	Metabolites
Alectinib Metabolite M1b	CS-O-32476	Metabolites
Alectinib acid impurity	CS-T-96143	Intermediates
Alectinib acid tert-butyl ester Intermediate	CS-T-96144	Intermediates